Ripretinib, sold under the brand name Qinlock, is a medication for the treatment of adults with advanced gastrointestinal stromal tumor (GIST), a type of tumor that originates in the gastrointestinal tract. It is taken by mouth.Ripretinib inhibits the activity of the kinases KIT and PDGFRA, which helps keep cancer cells from growing.[
| CAS No. | 1296903-66-5 |
| Molecular Weight (g/mol) | 510.3800 |
| Molecular Formula | C24H21BrFN5O2 |